[{"id":"e3dd3b03-34a4-4039-b048-c8e30407a19a","acronym":"AGO-Gard","url":"https://clinicaltrials.gov/study/NCT05266898","created_at":"2022-03-04T15:53:27.783Z","updated_at":"2025-02-25T16:17:22.034Z","phase":"Phase 4","brief_title":"Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV","source_id_and_acronym":"NCT05266898 - AGO-Gard","lead_sponsor":"Louisiana State University Health Sciences Center in New Orleans","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Gardasil 9 (human papillomavirus 9-valent vaccine, recombinant)"],"overall_status":"Recruiting","enrollment":" Enrollment 150","initiation":"Initiation: 11/30/2022","start_date":" 11/30/2022","primary_txt":" Primary completion: 06/01/2024","primary_completion_date":" 06/01/2024","study_txt":" Completion: 03/01/2025","study_completion_date":" 03/01/2025","last_update_posted":"2023-03-15"},{"id":"8c5881b3-5e09-4b5e-a3f6-07cd4392e894","acronym":"","url":"https://clinicaltrials.gov/study/NCT03947775","created_at":"2021-01-29T07:19:19.686Z","updated_at":"2025-02-25T16:09:08.380Z","phase":"Phase 2","brief_title":"HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL","source_id_and_acronym":"NCT03947775","lead_sponsor":"University Health Network, Toronto","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Gardasil 9 (human papillomavirus 9-valent vaccine, recombinant)"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 228","initiation":"Initiation: 09/01/2022","start_date":" 09/01/2022","primary_txt":" Primary completion: 03/01/2026","primary_completion_date":" 03/01/2026","study_txt":" Completion: 05/01/2026","study_completion_date":" 05/01/2026","last_update_posted":"2022-06-13"}]